John F. DiPersio, M.D., Ph.D.

Publications

• Martin MG, Augustin KM, Uy GL, Welch JS, Hladnik L, Goyal S, Tiwari D, Monahan RS, Reichley RM, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, DiPersio JF, Vij R
  Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
  Am J Hematol 2009 Sep 11; [Epub ahead of print]
• Dubberke ER, Reske KA, Srivastava A, Sadhu J, Gatti R, Young RM, Rakes LC, Dieckgraefe B, DiPersio J, Fraser VJ
  Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes.
  Clin Transplant 2009 Jul 13; [Epub ahead of print]
• DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G
  Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.
  J Clin Oncol 2009 Oct 1;27(28):4767-73
• Martin MG, Walgren RA, Procknow E, Uy GL, Stockerl-Goldstein K, Cashen AF, Westervelt P, Abboud CN, Kreisel F, Augustin K, DiPersio JF, Vij R
  A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
  Am J Hematol 2009 Sep;84(9):560-4
• Schaefer EW, Loaiza-Bonilla A, Juckett M, DiPersio JF, Roy V, Slack J, Wu W, Laumann K, Espinoza-Delgado I, Gore SD
  A phase 2 study of vorinostat in acute myeloid leukemia.
  Haematologica 2009 Oct;94(10):1375-82
• Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Eldred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, Schindler JK, Pohl CS, Wallis JW, Shi X, Lin L, Schmidt H, Tang Y, Haipek C, Wiechert ME, Ivy JV, Kalicki J, Elliott G, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson MA, Baty J, Heath S, Shannon WD, Nagarajan R, Link DC, Walter MJ, Graubert TA, DiPersio JF, Wilson RK, Ley TJ
  Recurring mutations found by sequencing an acute myeloid leukemia genome.
  N Engl J Med 2009 Sep 10;361(11):1058-66
• Martin MG, Welch JS, Augustin K, Hladnik L, DiPersio JF, Abboud CN
  Cladribine in the treatment of acute myeloid leukemia: a single-institution experience.
  Clin Lymphoma Myeloma 2009 Aug;9(4):298-301
• Ramirez P, Rettig MP, Uy GL, Deych E, Holt MS, Ritchey JK, DiPersio JF
  BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.
  Blood 2009 Aug 13;114(7):1340-3
• Walter MJ, Payton JE, Ries RE, Shannon WD, Deshmukh H, Zhao Y, Baty J, Heath S, Westervelt P, Watson MA, Tomasson MH, Nagarajan R, O'Gara BP, Bloomfield CD, Mrozek K, Selzer RR, Richmond TA, Kitzman J, Geoghegan J, Eis PS, Maupin R, Fulton RS, McLellan M, Wilson RK, Mardis ER, Link DC, Graubert TA, DiPersio JF, Ley TJ
  Acquired copy number alterations in adult acute myeloid leukemia genomes.
  Proc Natl Acad Sci U S A 2009 Aug 4;106(31):12950-5
• Martin MG, Uy GL, Procknow E, Stockerl-Goldstein K, Cashen A, Westervelt P, Abboud CN, Augustin K, Luo J, DiPersio JF, Vij R
  Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
  Bone Marrow Transplant 2009 Jul;44(1):13-7
• Kantarjian H, Cortes J, Kim DW, Dorlhiac-Llacer P, Pasquini R, DiPersio J, Muller MC, Radich JP, Khoury HJ, Khoroshko N, Bradley-Garelik MB, Zhu C, Tallman MS
  Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.
  Blood 2009 Jun 18;113(25):6322-9
• DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Fruehauf S, Horwitz M, Cooper D, Bridger G, Calandra G
  Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
  Blood 2009 Jun 4;113(23):5720-6
• Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF
  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.
  Blood 2009 Jun 11;113(24):6206-14
• Uy GL, Goyal SD, Fisher NM, Oza AY, Tomasson MH, Stockerl-Goldstein K, DiPersio JF, Vij R
  Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study.
  Bone Marrow Transplant 2009 May;43(10):793-800
• Rettig MP, Ramirez P, Nervi B, DiPersio JF
  Chapter 2 CXCR4 and mobilization of hematopoietic precursors.
  Methods Enzymol 2009;460:57-90
• Druley TE, Hayashi R, Mansur DB, Zhang QJ, Barnes Y, Trinkaus K, Witty S, Thomas T, Klein EE, DiPersio JF, Adkins D, Shenoy S
  Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI.
  Bone Marrow Transplant 2009 Feb;43(4):307-14
• Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, Shannon WD, Nagarajan R, Walter MJ, Link DC, Graubert TA, DiPersio JF, Wilson RK
  DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
  Nature 2008 Nov 6;456(7218):66-72
• Wildes TM, Procknow E, Gao F, DiPersio JF, Vij R
  Dasatinib in relapsed or plateau-phase multiple myeloma.
  Leuk Lymphoma 2009 Jan;50(1):137-40
• Schroeder M, Rettig M, Ramirez P, DiPersio J
  Optimal mobilization of normal and leukemic stem cells via modulation of chemokine and integrin axes.
  AACR Educational Book, in Press 2009
• Cashen AF, Shah AK, Todt L, Fisher N, DiPersio J
  Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
  Cancer Chemother Pharmacol 2008 Apr;61(5):759-66
• Wildes TM, Augustin KM, Sempek D, Zhang QJ, Vij R, DiPersio JF, Devine SM
  Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
  Biol Blood Marrow Transplant 2008 Jul;14(7):840-6
• Ramirez P, DiPersio JF
  Therapy options in imatinib failures.
  Oncologist 2008 Apr;13(4):424-34
• Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF
  Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
  Biol Blood Marrow Transplant 2008 Sep;14(9):1045-56
• Pusic I, DiPersio JF
  The use of growth factors in hematopoietic stem cell transplantation.
  Curr Pharm Des 2008;14(20):1950-61
• Pasquale T, Tomada JR, Ghannoun M, DiPersio J, Bonilla H
  Emergence of Candida tropicalis resistant to caspofungin.
  J Antimicrob Chemother 2008 Jan;61(1):219
• Dubberke ER, Sadhu J, Gatti R, Reske KA, DiPersio JF, Devine SM, Fraser VJ
  Reply to Jaber et al.
  Infect Control Hosp Epidemiol 2008 Feb;29(2):189-190
• Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, Heath SE, Nagarajan R, Mardis ER, Wilson RK, Ley TJ, Tomasson MH
  Identification of somatic JAK1 mutations in patients with acute myeloid leukemia.
  Blood 2008 May 1;111(9):4809-12
• Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K, DiPersio J
  A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma.
  Biol Blood Marrow Transplant 2008 Nov;14(11):1253-61
• Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N, Devine H, Link DC, Calandra G, Bridger G, Westervelt P, DiPersio JF
  Rapid mobilization of functional donor hematopoietic cells without G-CSF using plerixafor, an antagonist of the CXCR4/SDF-1 interaction.
  Blood 2008 Aug 15;112(4):990-8
• Tomasson MH, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T, Ries RE, Lubman O, Fremont D, McLellan MD, Payton JE, Westervelt P, DiPersio JF, Link DC, Walter MJ, Graubert TA, Watson M, Baty J, Heath S, Shannon WD, Nagarajan R, Bloomfield CD, Mardis ER, Wilson RK, Ley TJ
  Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
  Blood 2008 May 1;111(9):4797-808
• Rizzieri DA, Feldman E, DiPersio JF, Gabrail N, Stock W, Strair R, Rivera VM, Albitar M, Bedrosian CL, Giles FJ
  A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malignancies.
  Clin Cancer Res 2008 May 1;14(9):2756-62
• Uy GL, Trivedi R, Peles S, Fisher NM, Zhang QJ, Tomasson MH, DiPersio JF, Vij R
  Bortezomib inhibits osteoclast activity in patients with multiple myeloma.
  Clin Lymphoma Myeloma 2007 Nov;7(9):587-9
• Fong T, Vij R, Vijayan A, DiPersio J, Blinder M
  Copper deficiency: an important consideration in the differential diagnosis of myelodysplastic syndrome.
  Haematologica 2007 Oct;92(10):1429-30
• Fong T, Trinkaus K, Adkins D, Vij R, Devine SM, Tomasson M, Goodnough LT, Lopez S, Graubert T, Shenoy S, DiPersio JF, Khoury HJ
  A Randomized Double-Blind Trial of Hydroxychloroquine for the Prevention of Chronic Graft-versus-Host Disease after Allogeneic Peripheral Blood Stem Cell Transplantation.
  Biol Blood Marrow Transplant 2007 Oct;13(10):1201-6
• Yuan W, Payton JE, Holt MS, Link DC, Watson MA, DiPersio JF, Ley TJ
  Commonly dysregulated genes in murine APL cells.
  Blood 2007 Feb 1;109(3):961-70
• Tiwari D, Gao F, Hidalgo J, Adkins DR, Vij R, DiPersio JF, Khoury HJ
  Prognostic significance of early lymphocyte recovery after post-autografting administration of GM-CSF in non-Hodgkin's lymphoma.
  Bone Marrow Transplant 2007 Oct;40(7):671-5
• Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF
  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.
  Exp Hematol 2007 Dec;35(12):1823-38
• Link DC, Kunter G, Kasai Y, Zhao Y, Miner T, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanne-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ
  Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
  Blood 2007 Sep 1;110(5):1648-55
• Hess DA, Bonde J, Craft TP, Wirthlin L, Hohm S, Lahey R, Todt LM, DiPersio JF, Devine SM, Nolta JA
  Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
  Biol Blood Marrow Transplant 2007 Apr;13(4):398-411
• Dubberke ER, Sadhu J, Gatti R, Reske KA, DiPersio JF, Devine SM, Fraser VJ
  Severity of Clostridium difficile-Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading System.
  Infect Control Hosp Epidemiol 2007 Feb;28(2):208-11
• Cashen AF, Nervi B, DiPersio J
  AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent.
  Future Oncol 2007 Feb;3(1):19-27
• Macmillan ML, Couriel D, Weisdorf DJ, Schwab G, Havrilla N, Fleming TR, Huang S, Roskos L, Slavin S, Shadduck RK, DiPersio J, Territo M, Pavletic S, Linker C, Heslop HE, Joachim Deeg H, Blazar BR
  A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease.
  Blood 2007 Mar 15;109(6):2657-62
• Pavletic SZ, Zhou G, Sobocinski K, Marti G, Doney K, DiPersio J, Feremans W, Foroni L, Goodman S, Prentice G, LeMaistre C, Bandini G, Ferrant A, Jacobsen N, Khouri I, Gale RP, Wiestner A, Giralt S, Montserrat E, Chan WC, Bredeson C
  Genetically identical twin transplantation for chronic lymphocytic leukemia.
  Leukemia 2007 Dec;21(12):2452-5
• Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR
  Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
  Biol Blood Marrow Transplant 2006 Jul;12(7):749-57
• Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM, Khoury HJ
  Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
  Bone Marrow Transplant 2006 Dec;38(12):813-9
• Cashen AF, Devine H, DiPersio J
  Second complete remission in an elderly patient with acute myeloid leukemia retreated with decitabine.
  Am J Hematol 2006 Jul;81(7):543-5
• Uy GL, Tomasson MH, Ruddell A, DiPersio JF, Vij R
  The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
  Haematologica 2006 Nov;91(11):1581-2
• Nervi B, Link DC, DiPersio JF
  Cytokines and hematopoietic stem cell mobilization.
  J Cell Biochem 2006 Oct 15;99(3):690-705
• Jones RB, Anasetti C, Appel P, DiPersio J, Heslop H, Lemaistre F, Silver S, Sirilla J, Stiff P
  ASBMT committee report: white paper on measurement of quality outcomes.
  Biol Blood Marrow Transplant 2006 May;12(5):594-7
• Verkruyse LA, Storch GA, Devine SM, DiPersio JF, Vij R
  Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.
  Bone Marrow Transplant 2006 Jan;37(1):51-6
• Shepherd RM, Capoccia BJ, Devine SM, DiPersio J, Trinkaus KM, Ingram D, Link DC
  Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.
  Blood 2006 Dec 1;108(12):3662-7
• Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, DiPersio JF, Adkins D
  Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
  Transfusion 2006 Jan;46(1):14-23
• Kantarjian H, Issa JP, Rosenfeld CS, Bennett JM, Albitar M, DiPersio J, Klimek V, Slack J, de Castro C, Ravandi F, Helmer R 3rd, Shen L, Nimer SD, Leavitt R, Raza A, Saba H
  Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
  Cancer 2006 Apr 15;106(8):1794-803
• Hennenfent KL, Augustin KM, DiPersio JF, Khoury H
  Is there a role for high-dose methylprednisolone in the treatment of hepatic regimen-related toxicity?
  Bone Marrow Transplant 2006 Jan;37(2):229
• Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ, Mohanakumar T, Rao A, Hayashi RJ
  A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders.
  Bone Marrow Transplant 2005 Feb;35(4):345-52
• Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, DiPersio J, Adkins D
  Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
  Blood 2005 Apr 15;105(8):3035-41
• Friedman J, Khoury H, Adkins D, Devine S, Nervi B, Edwards T, DiPersio J, Vij R
  Pilot study of 13cis-retinoic acid+dexamethasone+alpha interferon as maintenance therapy following high-dose chemotherapy and autologous stem cell transplant for multiple myeloma.
  Bone Marrow Transplant 2005 May;35(10):979-84
• Flomenberg N, DiPersio J, Calandra G
  Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
  Acta Haematol 2005;114(4):198-205
• Flomenberg N, Devine SM, DiPersio JF, Liesveld JL, McCarty JM, Rowley SD, Vesole DH, Badel K, Calandra G
  The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.
  Blood 2005 Sep 1;106(5):1867-74
• Devine SM, Brown RA, Mathews V, Trinkaus K, Khoury H, Adkins D, Vij R, Sempek D, Graubert T, Tomasson M, Goodnough LT, DiPersio JF
  Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone.
  Bone Marrow Transplant 2005 Sep;36(6):531-8
• Brenner W, Storch G, Buller R, Vij R, Devine S, DiPersio J
  West Nile Virus encephalopathy in an allogeneic stem cell transplant recipient: use of quantitative PCR for diagnosis and assessment of viral clearance.
  Bone Marrow Transplant 2005 Aug;36(4):369-70
• Rettig MP, Ritchey JK, Prior JL, Haug JS, Piwnica-Worms D, DiPersio JF
  Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
  J Immunol 2004 Sep 15;173(6):3620-30
• Mathews V, DiPersio JF
  Stem cell transplantation in acute myelogenous leukemia in first remission: what are the options?
  Curr Hematol Rep 2004 Jul;3(4):235-41
• Hoerr AL, Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, DiPersio JF, Khoury HJ
  Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.
  J Clin Oncol 2004 Nov 15;22(22):4561-6
• Hidalgo JD, Krone R, Rich MW, Blum K, Adkins D, Fan MY, Brown R, Devine S, Graubert T, Blum W, Tomasson M, Goodnough LT, Vij R, DiPersio J, Khoury H
  Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes.
  Bone Marrow Transplant 2004 Oct;34(7):615-9
• Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, DiPersio J, Adkins D
  Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
  Biol Blood Marrow Transplant 2004 May;10(5):310-9
• Devine SM, Flomenberg N, Vesole DH, Liesveld J, Weisdorf D, Badel K, Calandra G, DiPersio JF
  Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.
  J Clin Oncol 2004 Mar 15;22(6):1095-102
• Cashen AF, Link D, Devine S, DiPersio J
  Cytokines and stem cell mobilization for autologous and allogeneic transplantation.
  Curr Hematol Rep 2004 Nov;3(6):406-12
• Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, Zimonjic DB, Popescu NC, DiPersio JF, Ley TJ
  High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
  Blood 2003 Sep 1;102(5):1857-65
• Vij R, Khoury H, Brown R, Goodnough LT, Devine SM, Blum W, Adkins D, DiPersio JF
  Low-dose short-course intravenous ganciclovir as pre-emptive therapy for CMV viremia post allo-PBSC transplantation.
  Bone Marrow Transplant 2003 Oct;32(7):703-7
• Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D
  Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.
  Blood 2003 Mar 1;101(5):2067-9
• Rettig MP, Ritchey JK, Meyerrose TE, Haug JS, DiPersio JF
  Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease.
  Mol Ther 2003 Jul;8(1):29-41
• Reece DE, Foon KA, Chatterjee MB, Adkins D, Broun ER, Connaghan DG, DiPersio JF, Holland HK, Howard DA, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL
  Use of the Anti-idiotype Breast Cancer Vaccine 11D10 in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer.
  Clin Breast Cancer 2003 Feb;3 Suppl 4:S152-7
• Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, DiPersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA
  Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
  Biol Blood Marrow Transplant 2003 Sep;9(9):583-91
• Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH
  High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
  Blood 2003 Oct 1;102(7):2364-72
• Manna PP, Jaramillo A, Majumder K, Campbell LG, Fleming TP, Dietz JR, DiPersio JF, Mohanakumar T
  Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells.
  Breast Cancer Res Treat 2003 May;79(1):133-6
• List A, Beran M, DiPersio J, Slack J, Vey N, Rosenfeld CS, Greenberg P
  Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.
  Leukemia 2003 Aug;17(8):1499-507
• Ley TJ, Minx PJ, Walter MJ, Ries RE, Sun H, McLellan M, DiPersio JF, Link DC, Tomasson MH, Graubert TA, McLeod H, Khoury H, Watson M, Shannon W, Trinkaus K, Heath S, Vardiman JW, Caligiuri MA, Bloomfield CD, Milbrandt JD, Mardis ER, Wilson RK
  A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes.
  Proc Natl Acad Sci U S A 2003 Nov 25;100(24):14275-80
• Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, DiPersio JF
  Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.
  Biol Blood Marrow Transplant 2003 Nov;9(11):714-21
• Giles FJ, Fracasso PM, Kantarjian HM, Cortes JE, Brown RA, Verstovsek S, Alvarado Y, Thomas DA, Faderl S, Garcia-Manero G, Wright LP, Samson T, Cahill A, Lambert P, Plunkett W, Sznol M, DiPersio JF, Gandhi V
  Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia.
  Leuk Res 2003 Dec;27(12):1077-83
• Douer D, Hu W, Giralt S, Lill M, DiPersio J
  Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation.
  Oncologist 2003;8(2):132-40
• Devine SM, Adkins DR, Khoury H, Brown RA, Vij R, Blum W, DiPersio JF
  Recent advances in allogeneic hematopoietic stem-cell transplantation.
  J Lab Clin Med 2003 Jan;141(1):7-32
• Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D, Devine S
  Stem cell mobilization.
  Hematology (Am Soc Hematol Educ Program) 2003;:419-37
• Chohan R, Vij R, Adkins D, Blum W, Brown R, Tomasson M, Devine S, Graubert T, Goodnough LT, DiPersio JF, Khoury H
  Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
  Br J Haematol 2003 Oct;123(1):110-3
• Cashen A, DiPersio JF, Khoury H
  Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?
  J Clin Oncol 2003 Nov 15;21(22):4255-6
• Blum W, Khoury H, Lin HS, Vij R, Goodnough LT, Devine S, DiPersio J, Adkins D
  Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: a feasibility study.
  Biol Blood Marrow Transplant 2003 Jun;9(6):397-404
• Bauer G, Nolta JA, Walker JE, Devine S, DiPersio JF
  The design and construction of a GMP facility for cellular and gene therapy in an academic center-implementing new regulatory requirements.
  Stem Cell and Cell Ther 1:54-61, 2003
• Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB
  Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study.
  Infect Control Hosp Epidemiol 2003 Apr;24(4):269-74
• Anderson KB, Tan JS, File TM Jr, DiPersio JR, Willey BM, Low DE
  Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
  Clin Infect Dis 2003 Aug 1;37(3):376-81
• Westervelt P, Pollock JL, Oldfather KM, Walter MJ, Ma MK, Williams A, DiPersio JF, Ley TJ
  Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia.
  Proc Natl Acad Sci U S A 2002 Jul 9;99(14):9468-73
• Silverberg D, Kodali P, DiPersio J, Acus R, Askew M
  In vitro analysis of antifungal impregnated polymethylmethacrylate bone cement.
  Clin Orthop Relat Res 2002 Oct;(403):228-31
• Lewis JS Jr, Khoury H, Storch GA, DiPersio J
  PCR for the diagnosis of toxoplasmosis after hematopoietic stem cell transplantation.
  Expert Rev Mol Diagn 2002 Nov;2(6):616-24
• Jaramillo A, Majumder K, Manna PP, Fleming TP, Doherty G, DiPersio JF, Mohanakumar T
  Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer.
  Int J Cancer 2002 Dec 10;102(5):499-506
• Goodnough LT, DiPersio JF
  Issues in the management of cancer-related thrombocytopenia.
  Oncology (Huntingt) 2002 Nov;16(11):1558-67; discussion 1570, 1572-4
• Blum W, Brown R, Lin HS, Zehnbauer B, Khoury H, Goodnough LT, Westervelt P, Vij R, DiPersio J, Adkins D
  Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
  Biol Blood Marrow Transplant 2002;8(11):608-18
• Young PP, Goodnough LT, Westervelt P, DiPersio JF
  Immune hemolysis involving non-ABO/RhD alloantibodies following hematopoietic stem cell transplantation.
  Bone Marrow Transplant 2001 Jun;27(12):1305-10
• Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, Luger SM, Ma MK, Ley TJ, DiPersio JF
  Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide.
  Blood 2001 Jul 15;98(2):266-71
• Weitzmann MN, Cenci S, Rifas L, Haug J, DiPersio J, Pacifici R
  T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.
  J Bone Miner Res 2001 Feb;16(2):328-37
• Stewart AK, Vescio R, Schiller G, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, White M, DiPersio J, Anderson KC, Berenson J
  Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
  J Clin Oncol 2001 Sep 1;19(17):3771-9
• Reece DE, Foon KA, Battacharya-Chatterjee M, Adkins D, Broun ER, Connaghan DG, DiPersio JF, Holland HK, Howard DS, Hale GA, Klingemann HG, Munn RK, Raptis A, Phillips GL
  Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.
  Clin Breast Cancer 2001 Apr;2(1):52-8
• Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J
  Thrombopoietin therapy increases platelet yields in healthy platelet donors.
  Blood 2001 Sep 1;98(5):1339-45
• Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, Westervelt P, Trinkaus K, Lin HS, DiPersio J
  Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.
  Biol Blood Marrow Transplant 2001;7(6):352-8
• Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, Westervelt P, Trinkaus K, Goodnough LT, Hayashi RJ, Parker P, Forman SJ, DiPersio JF
  Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
  Bone Marrow Transplant 2001 May;27(10):1059-64
• Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S
  Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.
  Blood 2001 Sep 1;98(5):1346-51
• Weitzmann MN, Cenci S, Haug J, Brown C, DiPersio J, Pacifici R
  B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta.
  J Cell Biochem 2000 May;78(2):318-24
• Vij R, DiPersio J, Brown R, Trinkaus K, Abboud C, Meehan KR, Frenette G, Freytes C, Goodnough LT, Khoury H, Ponnuri J, Adkins D
  Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
  Bone Marrow Transplant 2000 Nov;26(9):947-53
• Vij R, Brown R, Shenoy S, Haug JS, Kaesberg D, Adkins D, Goodnough LT, Khoury H, DiPersio J
  Allogeneic peripheral blood stem cell transplantation following CD34+ enrichment by density gradient separation.
  Bone Marrow Transplant 2000 Jun;25(12):1223-8
• Vescio RA, Wu CH, Zheng L, Sheen D, Ma H, Liu J, Stewart AK, Ballester O, Noga SJ, Rugo H, Freytes C, Stadtmauer E, Sahebi F, Tarantolo S, Stiff P, Schiller GJ, White M, Jacobs C, DiPersio J, Anderson KC, Berenson JR
  Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
  Bone Marrow Transplant 2000 Jan;25(2):153-60
• Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R
  A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
  Biol Blood Marrow Transplant 2000;6(1):25-34
• Khoury H, Adkins D, Brown R, Vij R, Westervelt P, Trinkaus K, Goodnough LT, DiPersio JF
  Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation.
  Bone Marrow Transplant 2000 Jun;25(11):1197-201
• Khoury H, Adkins D, Brown R, Trinkaus K, Vij R, Miller G, Goodnough LT, DiPersio J
  Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
  Bone Marrow Transplant 2000 Apr;25(7):737-43
• Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF
  Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
  Bone Marrow Transplant 2000 Mar;25(5):489-94
• DiPersio JF, Schuster MW, Abboud CN, Winter JN, Santos VR, Collins DM, Sherman JW, Baum CM
  Mobilization of peripheral-blood stem cells by concurrent administration of daniplestim and granulocyte colony-stimulating factor in patients with breast cancer or lymphoma.
  J Clin Oncol 2000 Jul;18(14):2762-71
• DiPersio JF, Khoury H, Haug J, Vij R, Adkins DR, Goodnough LT, Brown RA
  Innovations in allogeneic stem-cell transplantation.
  Semin Hematol 2000 Jan;37(1 Suppl 2):33-41
• Adkins DR, Goodnough LT, Shenoy S, Brown R, Moellering J, Khoury H, Vij R, DiPersio J
  Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation.
  Blood 2000 Jun 1;95(11):3605-12
• Adkins DR, Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, Westervelt P, DiPersio JF
  Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
  Bone Marrow Transplant 2000 Dec;26(11):1239-41
• Khoury H, Adkins D, Brown R, Goodnough L, Gokden M, Roberts T, Storch G, DiPersio J
  Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection.
  Bone Marrow Transplant 1999 Feb;23(4):409-11
• Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP
  Mammaglobin expression in primary, metastatic, and occult breast cancer [In Process Citation]
  Cancer Res 1999 Jul 1;59(13):3028-31
• Vij R, Adkins DR, Brown RA, Khoury H, DiPersio JF, Goodnough T
  Unstable angina in a peripheral blood stem and progenitor cell donor given granulocyte-colony-stimulating factor.
  Transfusion 1999 May;39(5):542-3
• Verfaillie CM, Ploemacher R, DiPersio JF, Sutherland R, Serke S, Johnson H, Noga S, Negrin R
  Assays to determine hematopoietic stem cell content in blood and marrow grafts.
  Cytotherapy 1999;1:41-9
• Vescio R, Schiller G, Stewart AK, Ballester O, Noga S, Rugo H, Freytes C, Stadtmauer E, Tarantolo S, Sahebi F, Stiff P, Meharchard J, Schlossman R, Brown R, Tully H, Benyunes M, Jacobs C, Berenson R, DiPersio J, Anderson K, Berenson J
  Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.
  Blood 1999 Mar 15;93(6):1858-68
• Shenoy S, Mohanakumar T, Todd G, Westhoff W, Dunnigan K, Adkins DR, Brown RA, DiPersio JF
  Immune reconstitution following allogeneic peripheral blood stem cell transplants.
  Bone Marrow Transplant 1999 Feb;23(4):335-46
• Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL
  Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
  Bone Marrow Transplant 1999 Nov;24(10):1057-63
• Naughton M, Brown R, Adkins D, DiPersio J
  Tularemia--an unusual cause of a solitary pulmonary nodule in the post-transplant setting.
  Bone Marrow Transplant 1999 Jul;24(2):197-9
• Liesveld J, Duerst R, Rapoport A, Constine L, Abboud C, Packman C, Wedow L, Zwetsch L, McKenna B, Linder T, Silverman W, Swift S, Rowe J, DiPersio J
  Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
  Bone Marrow Transplant 1999 Sep;24(5):511-6
• Krieger MS, Schiller G, Berenson JR, Stewart K, Noga SJ, Ballester O, Tarantolo S, Stiff P, Kuhn D, Scherzo E, Sing A, Jacobs C, White JM, DiPersio J
  Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34+ cells.
  Bone Marrow Transplant 1999 Jul;24(1):25-8
• Khoury H, Adkins D, Brown R, Goodnough L, Gokden M, Roberts T, Storch G, DiPersio J
  Successful treatment of cerebral toxoplasmosis in a marrow transplant recipient: contribution of a PCR test in diagnosis and early detection.
  Bone Marrow Transplant 1999 Feb;23(4):409-11
• Goodnough LT, Ali S, Despotis G, Dynis M, DiPersio JF
  Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy.
  Vox Sang 1999;76(1):43-9
• Faraday N, Rade JJ, Johns DC, Khetawat G, Noga SJ, DiPersio JF, Jin Y, Nichol JL, Haug JS, Bray PF
  Ex vivo cultured megakaryocytes express functional glycoprotein IIb-IIIa receptors and are capable of adenovirus-mediated transgene expression.
  Blood 1999 Dec 15;94(12):4084-92
• Brown RA, Adkins D, Khoury H, Vij R, Goodnough LT, Shenoy S, DiPersio JF
  Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: graft-versus-host disease and transplant-related mortality.
  J Clin Oncol 1999 Mar;17(3):806-12
• Bodo I, Peters M, Radich JP, Hess J, Blinder M, Watson MS, Van Rheeden R, Natarajan S, Lowell JA, Brown R, DiPersio J, Adkins D
  Donor-derived acute promyelocytic leukemia in a liver-transplant recipient.
  N Engl J Med 1999 Sep 9;341(11):807-13
• Adkins D, Brown R, Trinkaus K, Maziarz R, Luedke S, Freytes C, Needles B, Wienski D, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J
  Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
  J Clin Oncol 1999 Jul;17(7):2006-14
• Adkins D, Brown R, Goodnough L, Khoury H, DiPersio J
  Purine analog regimens for allogeneic transplant?
  J Clin Oncol 1999 Jun;17(6):1958-60
• Lancet JE, Rapoport AP, Brasacchio R, Eberly S, Raubertas RF, Linder T, Muhs A, Duerst RE, Abboud CN, Packman CH, DiPersio JF, Constine LS, Rowe JM, Liesveld JL
  Autotransplantation for relapsed or refractory Hodgkin's disease: long- term follow-up and analysis of prognostic factors.
  Bone Marrow Transplant 1998 Aug;22(3):265-71
• Khoury H, Adkins D, Zehnbauer B, Goodnough L, Brown R, Safdar S, DiPersio JF
  Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
  Bone Marrow Transplant 1998 Jul;22(1):107-9
• Bernstein SH, Nademanee AP, Vose JM, Tricot G, Fay JW, Negrin RS, DiPersio J, Rondon G, Champlin R, Barnett MJ, Cornetta K, Herzig GP, Vaughan W, Geils G Jr, Keating A, Messner H, Wolff SN, Miller KB, Linker C, Cairo M, Hellmann S, Ashby M, Stryker S, Nash RA
  A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
  Blood 1998 May 1;91(9):3509-17
• Adkins DR, Brown RA, DiPersio JF
  Patient selection in high-dose trials of breast cancer [letter; comment]
  J Clin Oncol 1998 Mar;16(3):1238-9
• Adkins D, Brown R, Goodnough LT, Khoury H, Popovic W, DiPersio J
  Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation.
  Bone Marrow Transplant 1998 Jan;21(1):97-9
• Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM
  Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors.
  Bone Marrow Transplant 1997 May;19(9):883-90
• Khoury H, Adkins D, Miller G, Goodnough L, Brown R, DiPersio J
  Resolution of invasive central nervous system aspergillosis in a transplant recipient [see comments].
  Bone Marrow Transplant 1997 Jul;20(2):179-80
• Graubert TA, DiPersio JF, Russell JH, Ley TJ
  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.
  J Clin Invest 1997 Aug 15;100(4):904-11
• Gamba MA, Martinelli M, Schaad HJ, Streuli RA, DiPersio J, Matter L, Ris HB, Marchal F, Kaplan EL, Stevens DL, Malinverni R
  Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review.
  Clin Infect Dis 1997 Jun;24(6):1118-21
• Brown RA, Adkins D, Goodnough LT, Haug JS, Todd G, Wehde M, Hendricks D, Ehlenbeck C, Laub L, DiPersio J
  Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies.
  J Clin Oncol 1997 Sep;15(9):3067-74
• Adkins DR, Brown RA, DiPersio JF
  Granulocyte-macrophage colony-stimulating factor with induction treatment of acute myelogenous leukemia [letter; comment].
  J Clin Oncol 1997 Feb;15(2):862-3
• Rapoport AP, Luhowskyj S, Doshi P, DiPersio JF
  Mutational analysis of the alpha subunit of the human interleukin-3 receptor.
  Blood 1996 Jan 1;87(1):112-22
• Matayoshi A, Brown C, DiPersio JF, Haug J, Abu-Amer Y, Liapis H, Kuestner R, Pacifici R
  Human blood-mobilized hematopoietic precursors differentiate into osteoclasts in the absence of stromal cells.
  Proc Natl Acad Sci U S A 1996 Oct 1;93(20):10785-90
• Wilhide CC, Van Dang C, DiPersio J, Kenedy AA, Bray PF
  Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest.
  Blood 1995 Jul 1;86(1):294-304
• Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL, Abboud CN, Packman CH, Eberly SW, Sherman M, et al
  Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.
  Bone Marrow Transplant 1995 Apr;15(4):523-30
• Martin BA, Rowe JM, Kouides PA, DiPersio JF
  Hepatitis B reactivation following allogeneic bone marrow transplantation: case report and review of the literature.
  Bone Marrow Transplant 1995 Jan;15(1):145-8
• Gaspari AA, Cheng SF, DiPersio JF, Rowe JM
  Roquinimex-induced graft-versus-host reaction after autologous bone marrow transplantation.
  J Am Acad Dermatol 1995 Nov;33(5 Pt 1):711-7
• Blumberg N, Heal JM, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM
  Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis.
  Am J Hematol 1995 Feb;48(2):108-15
• Winslow JM, Liesveld JL, Ryan DH, DiPersio JF, Abboud CN
  CD34+ progenitor cell isolation from blood and marrow: a comparison of techniques for small-scale selection.
  Bone Marrow Transplant 1994 Aug;14(2):265-71
• Liesveld JL, Keng PC, Rowe JM, DiPersio JF, Abboud CN
  Effects of GM-CSF on Ki67 expression and cell cycle traverse in acute myelogenous leukemia specimens and cell lines.
  Leuk Res 1994 Aug;18(8):609-16
• Liesveld JL, Frediani KE, Harbol AW, DiPersio JF, Abboud CN
  Characterization of the adherence of normal and leukemic CD34+ cells to endothelial monolayers.
  Leukemia 1994 Dec;8(12):2111-7
• Liesveld JL, DiPersio JF, Abboud CN
  Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic.
  Leuk Lymphoma 1994 Jun;14(1-2):19-28
• Heal JM, Blumberg N, Kirkley SA, DiPersio JF, Rapoport AP, Rowe JM
  Leukocyte-reduced transfusions of ABO-identical platelets and clinical outcome in autologous bone marrow transplantation for lymphoma.
  Bone Marrow Transplant 1994 Dec;14(6):943-8
• Doshi PD, DiPersio JF
  Three conserved motifs in the extracellular domain of the human granulocyte-macrophage colony-stimulating factor receptor subunit are essential for ligand binding and surface expression.
  Blood 1994 Oct 15;84(8):2539-53
• Rowe JM, Ryan DH, DiPersio JF
  Treatment of chronic myelogenous leukemia with autologous bone-marrow transplantation followed by the immunomodulator roquinimex (linomide).
  Exp Hematol 1993;21:1020
• Rowe J, Ryan D, DiPersio J, Gaspari A, Nilsson B, Larsson L, Liesveld J, Kouides P, Simonsson B
  Autografting in chronic myelogenous leukemia followed by immunotherapy.
  Stem Cells (Dayt) 1993 Oct;11 Suppl 3:34-42
• Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA, DiPersio JF
  One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.
  J Clin Oncol 1993 Dec;11(12):2351-61
• Rapoport AP, DiPersio JF
  Sequence analysis and functional studies of interleukin-3 receptor alpha subunit-encoding cDNAs amplified from KG-1 leukemic cells and normal human marrow.
  Gene 1993 Dec 31;137(2):333-7
• Kohn EC, Hollister GH, DiPersio JF, Wahl S, Liotta LA, Schiffmann E
  Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration.
  Int J Cancer 1993 Apr 1;53(6):968-72
• Rapoport AP, Rowe JM, Heal JM, Tanner MA, DiPersio JF
  Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue.
  Am J Hematol 1992 Jun;40(2):86-92
• Rapoport AP, Abboud CN, DiPersio JF
  Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): receptor biology, signal transduction, and neutrophil activation.
  Blood Rev 1992 Mar;6(1):43-57
• DiPersio JF, Abboud CN
  Activation of neutrophils by granulocyte-macrophage colony-stimulating factor.
  Immunol Ser 1992;57:457-84
• Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF
  Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
  Bone Marrow Transplant 1991 Nov;8(5):421-4
• Raines MA, Liu L, Quan SG, Joe V, DiPersio JF, Golde DW
  Identification and molecular cloning of a soluble human granulocyte- macrophage colony-stimulating factor receptor.
  Proc Natl Acad Sci U S A 1991 Sep 15;88(18):8203-7
• McColl SR, DiPersio JF, Caon AC, Ho P, Naccache PH
  Involvement of tyrosine kinases in the activation of human peripheral blood neutrophils by granulocyte-macrophage colony-stimulating factor.
  Blood 1991 Oct 1;78(7):1842-52
• DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC
  Characterization of the soluble human granulocyte-macrophage colony- stimulating factor receptor complex.
  J Biol Chem 1991 Jan 5;266(1):279-86
• Gasson JC, Baldwin GC, Sakamoto KM, DiPersio JF
  The biology of human granulocyte-macrophage colony-stimulating factor (GM-CSF).
  Prog Clin Biol Res 1990;352:375-84
• DiPersio JF, Golde DW, Gasson JD
  GM-CSF: receptor structure and transmembrane signaling.
  Int J Cell Cloning 1990 Jan;8 Suppl 1:63-74; discussion 74-5
• DiPersio JF
  Colony-stimulating factors: enhancement of effector cell function.
  Cancer Surv 1990;9(1):81-113
• Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF
  Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.
  Blood 1990 Feb 15;75(4):851-7
• McColl SR, Kreis C, DiPersio JF, Borgeat P, Naccache PH
  Involvement of guanine nucleotide binding proteins in neutrophil activation and priming by GM-CSF.
  Blood 1989 Feb;73(2):588-91
• Kaufman SE, DiPersio JF, Gasson JC
  Effects of human GM-CSF on neutrophil degranulation in vitro.
  Exp Hematol 1989 Aug;17(7):800-4
• Baldwin GC, Gasson JC, Kaufman SE, Quan SG, Williams RE, Avalos BR, Gazdar AF, Golde DW, DiPersio JF
  Nonhematopoietic tumor cells express functional GM-CSF receptors.
  Blood 1989 Mar;73(4):1033-7
• Nimer SD, Gasson JC, DiPersio JF
  The expression and target cell specificity of human granulocyte- macrophage colony-stimulating factor.
  Year Immunol 1988;3:144-51
• Naccache PH, Faucher N, Borgeat P, Gasson JC, DiPersio JF
  Granulocyte-macrophage colony-stimulating factor modulates the excitation-response coupling sequence in human neutrophils.
  J Immunol 1988 May 15;140(10):3541-6
• DiPersio JF, Naccache PH, Borgeat P, Gasson JC, Nguyen MH, McColl SR
  Characterization of the priming effects of human granulocyte-macrophage colony-stimulating factor on human neutrophil leukotriene synthesis.
  Prostaglandins 1988 Nov;36(5):673-91
• DiPersio JF, Billing P, Williams R, Gasson JC
  Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.
  J Immunol 1988 Jun 15;140(12):4315-22
• DiPersio J, Billing P, Kaufman S, Eghtesady P, Williams RE, Gasson JC
  Characterization of the human granulocyte-macrophage colony-stimulating factor receptor.
  J Biol Chem 1988 Feb 5;263(4):1834-41
• Munker R, DiPersio J, Koeffler HP
  Tumor necrosis factor: receptors on hematopoietic cells.
  Blood 1987 Dec;70(6):1730-4
• Silberstein DS, Owen WF, Gasson JC, DiPersio JF, Golde DW, Bina JC, Soberman R, Austen KF, David JR
  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.
  J Immunol 1986 Nov 15;137(10):3290-4
• Brennan JK, Abboud CN, DiPersio JF, Barlow GH, Lichtman MA
  Autostimulation of growth by human myelogenous leukemia cells (HL-60).
  Blood 1981 Oct;58(4):803-12
• DiPersio JF, Brennan JK, Lichtman MA, Abboud CN, Kirkpatrick FH
  The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT.
  Blood 1980 Oct;56(4):717-27
• Brennan JK, Lichtman MA, DiPersio JF, Abboud CN
  Chemical mediators of granulopoiesis: a review.
  Exp Hematol 1980 Apr;8(4):441-64
• Abboud CN, DiPersio JF, Brennan JK, Lichtman MA
  Erythropoietic enhancing activity (EEA) secreted by the human cell line, GCT.
  J Supramol Struct 1980;13(2):199-209
• Brennan JK, DiPersio JF, Abboud CN, Lichtman MA
  The exceptional responsiveness of certain human myeloid leukemia cells to colony-stimulating activity.
  Blood 1979 Dec;54(6):1230-9
• DiPersio JF, Brennan JK, Lichtman MA, Speiser BL
  Human cell lines that elaborate colon-stimulating activity for the marrow cells of man and other species.
  Blood 1978 Mar;51(3):507-19